View in EDS PDF Full Text

Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug.

Saved in:
Bibliographic Details
Title: Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug.
Authors: Capdeville R; Novartis Pharma AG, S-27 2.033, CH-4002 Basel, Switzerland. renaud.capdeville@pharma.novartis.com, Buchdunger E, Zimmermann J, Matter A
Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2002 Jul; Vol. 1 (7), pp. 493-502.
Publication Type: Journal Article; Review
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Print ISSN: 1474-1776 (Print) Linking ISSN: 14741776 NLM ISO Abbreviation: Nat Rev Drug Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 12120256
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Capdeville+R%22">Capdeville R</searchLink>; Novartis Pharma AG, S-27 2.033, CH-4002 Basel, Switzerland. renaud.capdeville@pharma.novartis.com<br /><searchLink fieldCode="AU" term="%22Buchdunger+E%22">Buchdunger E</searchLink><br /><searchLink fieldCode="AU" term="%22Zimmermann+J%22">Zimmermann J</searchLink><br /><searchLink fieldCode="AU" term="%22Matter+A%22">Matter A</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101124171%22">Nature reviews. Drug discovery</searchLink> [Nat Rev Drug Discov] 2002 Jul; Vol. 1 (7), pp. 493-502.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101124171 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>1474-1776 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214741776%22">14741776 </searchLink><i>NLM ISO Abbreviation: </i>Nat Rev Drug Discov <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=12120256
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/nrd839
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 493
    Titles:
      – TitleFull: Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Capdeville R
      – PersonEntity:
          Name:
            NameFull: Buchdunger E
      – PersonEntity:
          Name:
            NameFull: Zimmermann J
      – PersonEntity:
          Name:
            NameFull: Matter A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2002 Jul
              Type: published
              Y: 2002
          Identifiers:
            – Type: issn-print
              Value: 1474-1776
          Numbering:
            – Type: volume
              Value: 1
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Nature reviews. Drug discovery
              Type: main
ResultId 1